Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Changle International Limited SFWL SHENGFENG DEVELOPMENT Ltd 13G 9.6% 2y
M3 Funds, LLC FSEA First Seacoast Bancorp, Inc. 13G/A 8.11% 2y
Caledonia (Private) Investments Pty Ltd COUR Coursera, Inc. 13G/A 4.62% 2y
BECK MACK & OLIVER LLC RDNT RadNet, Inc. 13G/A 4.8% 2y
Second Century Ventures, LLC ( ) IDAI T Stamp Inc 13G 6.54% 2y
Kopernik Global Investors, LLC PPTA Perpetua Resources Corp. 13G 8.51% 2y
Lincoln Park Capital Fund, LLC KPRX Kiora Pharmaceuticals Inc 13G/A 9.99% 2y
RA CAPITAL MANAGEMENT, L.P. MGNX Macrogenics Inc 13G/A 6.5% 2y
BROWN CAPITAL MANAGEMENT LLC QTWO Q2 Holdings, Inc. 13G/A 4.36% 2y
AQR CAPITAL MANAGEMENT LLC GHIX Gores Holdings IX, Inc. Class A Common Stock 13G/A 5.8% 2y
Walleye Capital LLC ZPTA Zapata Quantum, Inc. 13G 7.49% 2y
BCP GP Limited EAF Graftech International Ltd 13G/A 10.6% 2y
Avidity Partners Management LP IDYA IDEAYA Biosciences, Inc. 13G/A 2.4% 2y
Deep Track Capital, LP SWTX SpringWorks Therapeutics, Inc. Common Stock 13G/A 5.53% 2y
Atlas OCM Holdings, LLC ALVO Alvotech 13G/A 3.93% 2y
FIR TREE CAPITAL MANAGEMENT LP BSLK Bolt Projects Holdings, Inc. 13G/A 0% 2y
ALLIANCEBERNSTEIN L.P. LITE Lumentum Holdings Inc. 13G/A 2.3% 2y
First Trust Capital Management L.P. TCOA Zalatoris Acquisition Corp. 13G 6.38% 2y
Magnolia Capital Fund, LP RMAX RE/MAX Holdings, Inc. 13G/A 16.4% 2y
Shchegolev Oleg SEMR SEMrush Holdings, Inc. 13G/A 39% 2y
CADIAN CAPITAL MANAGEMENT, LP MXCT Maxcyte, Inc. 13G 5.5% 2y
ALLIANCEBERNSTEIN L.P. TXCP Texas Capital Bancshares Inc 13G/A 4.5% 2y
GGV Capital V L.P. HCP HashiCorp, Inc. Class A Common Stock 13G/A 9.6% 2y
EcoR1 Capital, LLC ALGS Aligos Therapeutics, Inc. 13G/A 9.99% 2y
GLAZER CAPITAL, LLC GODN Golden Star Acquisition Corporation Ordinary Shares 13G 7.09% 2y
MASTERS CAPITAL MANAGEMENT LLC SONX Sonendo, Inc. 13G 9.2% 2y
Sculptor Capital LP RMCO Royalty Management Holding Corp 13G/A 0% 2y
NOMURA HOLDINGS INC KCGI Kensington Capital Acquisition Corp. V 13G 6.8% 2y
TYNDALL CAPITAL PARTNERS L P KRSA Korsana Biosciences, Inc. 13G/A 6.7% 2y
Charles Jones BLZE Backblaze, Inc. 13G/A 4.7% 2y
Encompass Capital Advisors LLC AMTX Aemetis, Inc 13G/A 4.43% 2y
PERCEPTIVE ADVISORS LLC CELC Celcuity Inc. 13G/A 6.1% 2y
Venrock Healthcare Capital Partners III, L.P. CABA Cabaletta Bio, Inc. 13G/A 6.4% 2y
David D. Chang, M.D., Ph.D. ALLO Allogene Therapeutics, Inc. 13G/A 5.8% 2y
Radcliffe Capital Management, L.P. DHAI DIH Holdings US, Inc. Class A Common Stock 13G/A 0% 2y
ALLIANCEBERNSTEIN L.P. CHRS Coherus Oncology, Inc. 13G/A 0.1% 2y
HARRIS ASSOCIATES L P LAD Lithia Motors Inc 13G 7.36% 2y
Apoorva Mehta CART Maplebear Inc. 13G 9.9% 2y
METEORA CAPITAL, LLC RDZN Roadzen Inc. 13G 5.97% 2y
MARCUS STEPHEN H MCS Marcus Corp 13G/A 14% 2y
CVC Capital Partners VI Ltd PLGO Pelagos Insurance Capital Ltd 13G 15.7% 2y
FPR PARTNERS LLC QVCAQ QVC Group, Inc. 13G/A 7.9% 2y
Jefferies Financial Group Inc. BCYC Bicycle Therapeutics PLC 13G 5.17% 2y
Hercules Holding II HCA HCA Healthcare, Inc. 13G/A 25.7% 2y
AWM Investment Company, Inc. GENK GEN Restaurant Group, Inc. 13G 5.2% 2y
Aristotle Capital Management, LLC WSM Williams Sonoma Inc 13G/A 7.15% 2y
Advent International, L.P. SOVO Sovos Brands, Inc. Common Stock 13G/A 42% 2y
WHITEBOX ADVISORS LLC REED Reed's, Inc. 13G/A 9.9% 2y
BLACK DIAMOND CAPITAL MANAGEMENT, L.L.C. SAR Saratoga Investment Corp. 13G/A 0% 2y
CANADA PENSION PLAN INVESTMENT BOARD KC Kingsoft Cloud Holdings Ltd 13G 8.7% 2y